Febrile reaction to subarachnoid baclofen administration

Anesthesiology

Volumn 96, Issue 5, 2002, Pages 1270-1272

  Wu, Shyh Shiun ^a   Dolan, Kevin A ^a   Ferrante, Michael F ^b,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; DIAZEPAM; TIZANIDINE;

ADULT; ARTICLE; BROWN SEQUARD SYNDROME; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SAFETY; FEMALE; FEVER; HUMAN; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD COMPRESSION;

ADULT; BACLOFEN; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FEMALE; FEVER; GABA AGONISTS; HUMANS; INJECTIONS; SUBARACHNOID SPACE;

EID: 0036241024     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200205000-00037     Document Type: Article

References (13)

1. Intrathecal baclofen for severe spinal spasticity
2. Continuous intrathecal baclofen infusion for spasticity of cerebral origin
3. Intrathecal baclofen for spasticity of spinal origin: Seven years experience
4. Drug therapy: Spasticity
5. Management of spasticity
6. Antispasticity drugs: Mechanism of action
7. Death after acute withdrawal of intrathecal baclofen: Case report and literature review
8. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure
9. B receptor sites involvement in rat thermoregulation
10. Opioid and prostaglandin mechanisms involved in the effects of GABAergic drugs on body temperature
11. Studies of the third circulation: Amipaque CT cisternography and ventriculography
12. Observations on the circulation of cerebrospinal fluid